EUVIMEDEUVIMED entdecken
Crossref

Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites

Ana L. Valdez-Arellanes, Lourdes Garza-Ocañas, Christian T. Badillo-Castañeda

Revista Medicina Universitaria · 10.04.2026 · 28 (2)

DOI: 10.24875/rmu.25000043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Medicina Universitaria, online erschienen am 10.04.2026. Verfasst von Ana L. Valdez-Arellanes und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Valdez-Arellanes, A. L., Garza-Ocañas, L., & Badillo-Castañeda, C. T. (2026). Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites. Revista Medicina Universitaria, 28(2). https://doi.org/10.24875/rmu.25000043

Vancouver

Valdez-Arellanes AL, Garza-Ocañas L, Badillo-Castañeda CT. Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites. Revista Medicina Universitaria. 2026;28(2). doi:10.24875/rmu.25000043

BibTeX
@article{ValdezArellanes2026,
  author = {Valdez-Arellanes, Ana L. and Garza-Ocañas, Lourdes and Badillo-Castañeda, Christian T.},
  title = {Optimizing therapy in pediatric acute lymphoblastic leukemia (ALL ): the crucial role of monitoring 6-mercaptopurine metabolites},
  journal = {Revista Medicina Universitaria},
  year = {2026},
  volume = {28},
  number = {2},
  doi = {10.24875/rmu.25000043}
}
Kostenlos starten →